Factors of Response to Pegylated Interferon/Ribavirin Combination Therapy and Mechanism of Viral Clearance
Author(s) -
Kumiko Sugimoto,
Soo Ryang Kim,
Ahmed El-Shamy,
Susumu Imoto,
Kenji Ando,
Ke Ih Kim,
Yasuhito Tanaka,
Yoshihiko Yano,
Soo Ki Kim,
Yutaka Hasegawa,
Aya Fujinami,
Mitsuhiro Ohta,
Takashi Hatori,
Hak Hotta,
Yoshitake Hayashi,
Masatoshi Kudo
Publication year - 2013
Publication title -
digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.879
H-Index - 66
eISSN - 1421-9875
pISSN - 0257-2753
DOI - 10.1159/000355239
Subject(s) - ribavirin , medicine , pegylated interferon , combination therapy , gastroenterology , viral load , interferon , univariate analysis , immunology , multivariate analysis , virus , hepatitis c virus
This study explores viral factors of the interferon (IFN) and ribavirin (RBV) resistance-determining region (IRRDR), the IFN sensitivity-determining region (ISDR) and the core protein, and host factor interleukin 28B associated with response to pegylated IFN (PEG-IFN) and RBV combination therapy, and the correlation of viral and host factors with IFN-λ1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom